733745-73-8Relevant articles and documents
5-HT7 RECEPTOR ANTAGONISTS
-
Page/Page column 15; 16, (2009/05/28)
The present invention provides selective 5-HT7 receptor antagonist compounds of Formula I and their use in the treatment of migraine: where A is C(H)= or -N= and R1-7 are as defined herein.
NOVEL COMPOUNDS
-
Page 40, (2010/02/07)
The invention relates to thienopyridazinones of formula (I): wherein: R1 is C1-6 alkyl, C2-6 alkenyl or C3-6 cycloalkyl which is optionally substituted by C1-6 alkyl, each of the above being optionall